Jonathan Elliott Katz

Jonathan Katz practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Jonathan Katz's NPI, 1952756207, was assigned on April 24, 2016. Jonathan Katz graduated from University of Miami, Miller School of Medicine in 2017. Jonathan Katz holds Florida license 169334.

Jonathan Katz's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Jonathan Katz's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Jonathan Katz is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Jonathan Katz practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Jonathan Katz's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Jonathan Katz's licenses on file in 2 states: Florida and California.

Dmand AI lists enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease, urinary endoscopy and urine flow blockage among the conditions Jonathan Katz treats.

CMS data shows 79 Medicare services from Jonathan Katz across 3 procedure codes in 2024, all of them office visits, for 124 Medicare patients. Medicare paid $7,752 for them.

CMS counts 124 Medicare patients who saw Jonathan Katz in 2024. The largest group is 65 to 74, with 58 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jonathan Katz's median patient age at 64, with 30% women.

In 2024, Jonathan Katz wrote 384 Medicare Part D claims for 144 patients. 90% of them were for generic drugs. CMS names the drug for 266 of them, across 9 drugs with 11 or more claims each, at $29,610 in total drug cost. In 2023, CMS named 256 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Jonathan Katz for performance year 2024, reported as part of a group. Jonathan Katz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Jonathan Katz as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 35 general payments to Jonathan Katz from 10 drug and device companies from 2018 to 2025. Grants make up the largest share, 83% of the total. Boston Scientific Corporation paid the most, $26,005.

Jonathan Katz graduated from University of Miami, Miller School of Medicine in 2017.

Jonathan Katz is in network with 8 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.